Milestones boost Genmab's first-quarter revenues
This article was originally published in Scrip
Executive Summary
Genmab's first-quarter revenues rose by 51% to DKK252 million ($46 million) in the first quarter of 2009 on the back of milestones and one-off payments. Analysts' consensus estimates of revenues were considerably lower, at DKK166 million.